Evidence map›Paper›PMID 21883211›Full record

ArticleJournal of neurochemistry2011

A steroid modulatory domain in NR2A collaborates with NR1 exon-5 to control NMDAR modulation by pregnenolone sulfate and protons.

Emmanuel Kostakis, Ming-Kuei Jang, Shelley J Russek, Terrell T Gibbs, David H Farb

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Journal of neurochemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
0.8field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. A GlutamateThe Journal of pharmacology and experimental therapeutics · 2021
    Article
  7. Review
  8. Site of Action of Brain Neurosteroid Pregnenolone Sulfate at the N-Methyl-D-Aspartate Receptor.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2020
    Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Lens Biology is a Dimension of Neurobiology.Neurochemical research · 2017
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Emmanuel KostakisDepartment of Pharmacology & Experimental Therapeutics, Boston University School of Medicine, Boston, MA 02118, USA.
Ming-Kuei Jang
Shelley J Russek
Terrell T Gibbs
David H Farb
Boston University · US

Funding

TRAINING IN BIOMOLECULAR PHARMACOLOGYT32GM008541 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI FARB, DAVID H · 1997 to 2022
$5.2M
STEROIDS--FUNCTIONAL MODULATORS OF AMINO ACID RECEPTORSR01MH049469 · NIMH · BOSTON UNIVERSITY MEDICAL CAMPUS · PI FARB, DAVID H · 1992 to 2007
$2.5M
NIGMS NIH HHS GM T32 008541NIGMS NIH HHS T32 GM008541NIMH NIH HHS R01 MH049469NIMH NIH HHS R01 MH49469
6 · The paper itself

Abstract

NMDA receptor (NMDAR)-mediated excitatory synaptic transmission plays a critical role in synaptic plasticity and memory formation, whereas its dysfunction may underlie neuropsychiatric and neurodegenerative diseases. The neuroactive steroid pregnenolone sulfate (PS) acts as a cognitive enhancer in impaired animals, augments LTP in hippocampal slices by enhancing NMDAR activity, and may participate in the reduction of schizophrenia's negative symptoms by systemic pregnenolone. We report that the effects of PS on NMDAR function are diverse, varying with subunit composition and NR1 splice variant. While PS potentiates NR1-1a/NR2B receptors through a critical steroid modulatory domain in NR2B that also modulates tonic proton inhibition, potentiation of the NMDA response is not dependent upon relief of such inhibition, a finding that distinguishes it from spermine. In contrast, the presence of an NR2A subunit confers enhanced PS-potentiation at reduced pH, suggesting that it may indeed act like spermine does at NR2B-containing receptors. Additional tuning of the NMDAR response by PS comes via the N-terminal exon-5 splicing insert of NR1-1b, which regulates the magnitude of proton-dependent PS potentiation. For NR2C- and NR2D-containing receptors, negative modulation at NR2C receptors is pH-independent (like NR2B) while negative modulation at NR2D receptors is pH-dependent (like NR2A). Taken together, PS displays a rich modulatory repertoire that takes advantage of the structural diversity of NMDARs in the CNS. The differential pH sensitivity of NMDAR isoforms to PS modulation may be especially important given the emerging role of proton sensors to both learning and memory, as well as brain injury.

Indexed as

ExonsProtonsAlternative SplicingAnimalsCrystallography, X-RayFemaleNeural InhibitionPoint MutationPregnenoloneProtein Structure, TertiaryProtein SubunitsRatsReceptors, N-Methyl-D-AspartateXenopus laevisNR1 NMDA receptorNR2A NMDA receptorPregnenolonepregnenolone sulfateProtein SubunitsProtonsReceptors, N-Methyl-D-Aspartate

Identifiers

PMID21883211
PMCPMC3360518
OpenAlexW1660643456

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.